Identifying Potential Novel Drugs Against Helicobacter Pylori by Targeting the Essential Response Regulator HsrA

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-47746-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Antimicrobial Activity of the Essential Oil of Thymus Capitatus Against Helicobacter Pylori

Acta Poloniae Pharmaceutica
PharmacologyPharmaceutical Science
2020English

Targeting the Β-Clamp in Helicobacter Pylori With FDA-approved Drugs Reveals Micromolar Inhibition by Diflunisal

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2017English

Gastric Mucosal Response to Helicobacter Pylori

Keio Journal of Medicine
Medicine
2002English

Ranitidine, a Potential Option for Helicobacter Pylori Eradication

European Journal of Therapeutics
2019English

In-Vitro Characterisation of a Novel Antimicrobial Agent, TNP-2092, Against Helicobacter Pylori Clinical Isolates

Swiss Medical Weekly
Medicine
2018English

Caveolin-1 Protects B6129 Mice Against Helicobacter Pylori Gastritis

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2013English

Probiotic Lactobacillus Spp. Act Against Helicobacter Pylori-Induced Inflammation

Journal of Clinical Medicine
2019English

Helicobacter Pylori

Gut
Gastroenterology
1992English

Direct Activity of Recombinant Human Lactoferrin Against Helicobacter Pylori.

Journal of Clinical Microbiology
Microbiology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy